Condensed Consolidated Statements of Stockholders’ Equity (Deficit) - USD ($) $ in Thousands	Total	TPK Universal Solutions Limited	Equity Financing Program	Additional Paid-in Capital	Additional Paid-in Capital TPK Universal Solutions Limited	Additional Paid-in Capital Equity Financing Program	Accumulated Other Comprehensive Loss	Treasury Stock	Accumulated Deficit	Class A Common Stock	Class A Common Stock Equity Financing Program	Class A Common Stock Common Stock	Class A Common Stock Common Stock TPK Universal Solutions Limited	Class A Common Stock Common Stock Equity Financing Program	Class B Common Stock	Class B Common Stock Common Stock
Beginning balance (in shares) at Dec. 31, 2021												266,076,525				97,088,670
Beginning balance at Dec. 31, 2021	$ 197,985			$ 1,257,214			$ (908)	$ (235,871)	$ (822,487)			$ 27				$ 10
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares repurchased	(76,606)							(76,606)
Issuance of Class A common stock upon exercise of Public and Private Warrants (in shares)												405,752
Issuance of Class A common stock upon exercise of Private Warrants	19,003			19,003
Issuance of Class A common stock upon exercise of stock options and vesting of restricted stock units (in shares)												4,185,398
Issuance of Class A common stock upon exercise of stock options and vesting of restricted stock units	1,744			1,744
Retirement of unvested restricted common stock (in shares)												(43,556)
Retirement of unvested restricted common stock	0
Vendor payments under the stock-in-lieu of cash program (in shares)												9,036,665
Vendor payments under the stock-in-lieu of cash program	43,758			43,757								$ 1
Consideration / milestone related to acquisitions (in shares)												2,550,398
Consideration / milestone related to acquisitions	33,871			33,871
Share-based compensation	59,199			59,199
Payments of employee taxes related to stock-based awards	(1,724)			(1,724)
Other comprehensive income (loss)	(5,097)						(5,097)
Net loss	(183,572)								(183,572)
Ending balance (in shares) at Jun. 30, 2022												282,211,182				97,088,670
Ending balance at Jun. 30, 2022	88,561			1,413,064			(6,005)	(312,477)	(1,006,059)			$ 28				$ 10
Beginning balance (in shares) at Mar. 31, 2022												269,978,536				97,088,670
Beginning balance at Mar. 31, 2022	123,884			1,314,742			(4,556)	(275,519)	(910,820)			$ 27				$ 10
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares repurchased	(36,958)							(36,958)
Issuance of Class A common stock upon exercise of Public and Private Warrants (in shares)												4,387
Issuance of Class A common stock upon exercise of Private Warrants	314			314
Issuance of Class A common stock upon exercise of stock options and vesting of restricted stock units (in shares)												2,068,339
Issuance of Class A common stock upon exercise of stock options and vesting of restricted stock units	659			659
Retirement of unvested restricted common stock (in shares)												(2,793)
Retirement of unvested restricted common stock	0
Vendor payments under the stock-in-lieu of cash program (in shares)												7,612,315
Vendor payments under the stock-in-lieu of cash program	29,145			29,144								$ 1
Consideration / milestone related to acquisitions (in shares)												2,550,398
Consideration / milestone related to acquisitions	33,871			33,871
Share-based compensation	35,542			35,542
Payments of employee taxes related to stock-based awards	(1,208)			(1,208)
Other comprehensive income (loss)	(1,449)						(1,449)
Net loss	(95,239)								(95,239)
Ending balance (in shares) at Jun. 30, 2022												282,211,182				97,088,670
Ending balance at Jun. 30, 2022	88,561			1,413,064			(6,005)	(312,477)	(1,006,059)			$ 28				$ 10
Beginning balance (in shares) at Dec. 31, 2022												291,942,087				97,088,670
Beginning balance at Dec. 31, 2022	(26,405)			1,558,685			(4,226)	(312,477)	(1,268,426)			$ 29				$ 10
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of Class A common stock upon exercise of stock options and vesting of restricted stock units (in shares)												8,725,129		3,765,292
Issuance of Class A common stock upon exercise of stock options and vesting of restricted stock units	1,649		$ 29,604	1,648		$ 29,604					$ 29,600	$ 1
Issuance of Class A common stock under employee stock purchase plan (ESPP) (in shares)												272,524
Issuance of Class A common stock under employee stock purchase plan (“ESPP”)	1,406			1,406
Vendor payments under the stock-in-lieu of cash program (in shares)												6,115,092
Vendor payments under the stock-in-lieu of cash program	33,595			33,594								$ 1
Consideration / milestone related to acquisitions (in shares)												1,415,613	1,652,892
Consideration / milestone related to acquisitions	9,320	$ 10,000		9,320	$ 10,000
Share-based compensation	97,368			97,368
Payments of employee taxes related to stock-based awards	(572)			(572)
Other comprehensive income (loss)	3,418						3,418
Net loss	(288,530)								(288,530)
Ending balance (in shares) at Jun. 30, 2023										292,025,179		313,888,629			97,088,670	97,088,670
Ending balance at Jun. 30, 2023	(129,147)			1,741,053			(808)	(312,477)	(1,556,956)			$ 31				$ 10
Beginning balance (in shares) at Mar. 31, 2023												301,045,203				97,088,670
Beginning balance at Mar. 31, 2023	(82,280)			1,647,357			(2,000)	(312,477)	(1,415,200)			$ 30				$ 10
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of Class A common stock upon exercise of stock options and vesting of restricted stock units (in shares)												4,009,392	1,652,892	1,005,603
Issuance of Class A common stock upon exercise of stock options and vesting of restricted stock units	610	$ 10,000	$ 6,939	610	$ 10,000	$ 6,939					$ 6,900
Issuance of Class A common stock under employee stock purchase plan (ESPP) (in shares)												272,524
Issuance of Class A common stock under employee stock purchase plan (“ESPP”)	1,406			1,406
Vendor payments under the stock-in-lieu of cash program (in shares)												4,487,402
Vendor payments under the stock-in-lieu of cash program	16,854			16,853								$ 1
Consideration / milestone related to acquisitions (in shares)												1,415,613
Consideration / milestone related to acquisitions	9,320			9,320
Share-based compensation	48,568			48,568
Other comprehensive income (loss)	1,192						1,192
Net loss	(141,756)								(141,756)
Ending balance (in shares) at Jun. 30, 2023										292,025,179		313,888,629			97,088,670	97,088,670
Ending balance at Jun. 30, 2023	$ (129,147)			$ 1,741,053			$ (808)	$ (312,477)	$ (1,556,956)			$ 31				$ 10